DRAVP ID Peptide Name Source Target Organism Patent No
DRAVPa1821 Sequence 43 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1822 Sequence 44 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1823 Sequence 45 from Patent US20040229219 A1 Mouse hepatitis virus SARS US20040229219 A1
DRAVPa1824 Sequence 46 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1825 Sequence 47 from Patent US20040229219 A1 Synthetic construct SARS US20040229219 A1
DRAVPa1826 Sequence 48 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1827 Sequence 49 from Patent US20040229219 A1 Mouse hepatitis virus SARS US20040229219 A1
DRAVPa1828 Sequence 50 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1829 Sequence 51 from Patent US20040229219 A1 Human coronavirus SARS US20040229219 A1
DRAVPa1830 Sequence 52 from Patent US20040229219 A1 Mouse hepatitis virus SARS US20040229219 A1
DRAVPa1831 Sequence 1 from Patent US20170058000 B2 Synthetic construct H3N2 US20170058000 B2
DRAVPa1832 Sequence 12 from Patent US20170058000 B2 Synthetic construct H3N2 US20170058000 B2
DRAVPa1833 Sequence 14 from Patent US20170058000 B2 Synthetic construct H3N2 US20170058000 B2
DRAVPa1834 Sequence 15 from Patent US20170058000 B2 Synthetic construct H3N2 US20170058000 B2
DRAVPa1835 Sequence 16 from Patent US20170058000 B2 Synthetic construct H3N2 US20170058000 B2
DRAVPa1836 Sequence 17 from Patent US20170058000 B2 Synthetic construct H3N2 US20170058000 B2
DRAVPa1837 Sequence 18 from Patent US20170058000 B2 Synthetic construct H3N2 US20170058000 B2
DRAVPa1838 Sequence 19 from Patent US20170058000 B2 Synthetic construct H3N2 US20170058000 B2
DRAVPa1839 Sequence 20 from Patent US20170058000 B2 Synthetic construct H3N2 US20170058000 B2
DRAVPa1840 Sequence 2 from Patent US20170058000 B2 Synthetic construct H3N2 US20170058000 B2
First 89 90 91 92 93 94 95 Last